Trial Profile

A Randomised Phase III Study for Evaluating the Role of the Addition of Ovarian Function Suppression to Tamoxifen in Young Women With Hormone-Sensitive Breast Cancer Who Remain in Premenopause or Regain Menstruation After Chemotherapy

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Nov 2024 Results (n=957) assessing Prediction of menstrual recovery patterns in premenopausal women with breast cancer taking tamoxifen after chemotherapy published in the Breast Cancer Research
22 Aug 2023 Results of a 8year follow up of the ASTRRA trial published in the Journal of Clinical Oncology.
07 Jun 2022 Results (n=1293) of a retrospective analysis assessing mammographic breast density reduction rate and its impact on prognosis stratified by treatment presented at the 58th Annual Meeting of the American Society of Clinical Oncology

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com